- Home
- BBD vs GEHC Comparison
BBD vs GEHC Comparison
Compare BBD & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBD
- GEHC
- Stock Information
- Founded
- BBD 1943
- GEHC 1892
- Country
- BBD Brazil
- GEHC United States
- Employees
- BBD N/A
- GEHC N/A
- Industry
- BBD Major Banks
- GEHC Computer Software: Prepackaged Software
- Sector
- BBD Finance
- GEHC Technology
- Exchange
- BBD Nasdaq
- GEHC Nasdaq
- Market Cap
- BBD 30.6B
- GEHC 33.1B
- IPO Year
- BBD N/A
- GEHC N/A
- Fundamental
- Price
- BBD $3.12
- GEHC $74.56
- Analyst Decision
- BBD Strong Buy
- GEHC Buy
- Analyst Count
- BBD 4
- GEHC 7
- Target Price
- BBD $2.55
- GEHC $84.14
- AVG Volume (30 Days)
- BBD 55.2M
- GEHC 3.4M
- Earning Date
- BBD 10-29-2025
- GEHC 10-29-2025
- Dividend Yield
- BBD 5.30%
- GEHC 0.19%
- EPS Growth
- BBD 58.81
- GEHC 41.40
- EPS
- BBD 0.36
- GEHC 4.88
- Revenue
- BBD $16,114,445,927.00
- GEHC $19,967,000,000.00
- Revenue This Year
- BBD $77.46
- GEHC $6.03
- Revenue Next Year
- BBD $7.42
- GEHC $4.61
- P/E Ratio
- BBD $8.27
- GEHC $15.26
- Revenue Growth
- BBD 27.09
- GEHC 2.31
- 52 Week Low
- BBD $1.84
- GEHC $57.65
- 52 Week High
- BBD $3.41
- GEHC $94.80
- Technical
- Relative Strength Index (RSI)
- BBD 44.92
- GEHC 49.34
- Support Level
- BBD $3.13
- GEHC $69.79
- Resistance Level
- BBD $3.20
- GEHC $77.94
- Average True Range (ATR)
- BBD 0.07
- GEHC 1.71
- MACD
- BBD -0.03
- GEHC 0.12
- Stochastic Oscillator
- BBD 6.25
- GEHC 57.61
About BBD Banco Bradesco Sa
Banco Bradesco is Brazil's second-largest private bank, with about 10%-15% of deposits, and the largest insurance provider in Brazil, with roughly 20%-25% market share. The bank is majority controlled by the Bradesco foundation—a private nonprofit institution focused on education. The bank is also a major asset manager with high-single-digit market share. In 2016, Bradesco acquired the Brazilian operations of HSBC.
About GEHC GE HealthCare Technologies Inc.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).